Verano Holdings (VRNO) Liabilities and Shareholders Equity (2021 - 2026)

Verano Holdings (VRNO) reported Liabilities and Shareholders Equity of $1.7 billion for Q1 2026, down 13.24% year-over-year from $2.0 billion in Q1 2025, and down 1.91% quarter-over-quarter from $1.7 billion in Q4 2025.

Verano Holdings (VRNO) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $1.7 billion in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $1.7 billion, down 13.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 billion (down 14.09% YoY), and the FY2025 annual result was $1.7 billion, down 12.66% from the prior year.
  • Liabilities and Shareholders Equity eased to $1.7 billion in Q1 2026 per VRNO's latest filing, from $1.7 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $2.6 billion in Q3 2022 and troughed at $1.7 billion in Q1 2026.
  • A 5-year average of $2.2 billion and a median of $2.3 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity dropped 1.72% in 2024, then dropped 16.82% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.4 billion in 2022, then slipped by 3.23% to $2.3 billion in 2023, then retreated by 14.0% to $2.0 billion in 2024, then slipped by 12.66% to $1.7 billion in 2025, then slipped by 1.91% to $1.7 billion in 2026.
  • Business Quant data shows VRNO's Liabilities and Shareholders Equity at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Verano Holdings - - 98.98 Mn 1.71 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.71 Bn
Dec 31, 2025 1.74 Bn
Sep 30, 2025 1.93 Bn
Jun 30, 2025 1.94 Bn
Mar 31, 2025 1.97 Bn
Dec 31, 2024 1.99 Bn
Sep 30, 2024 2.31 Bn
Jun 30, 2024 2.24 Bn
Mar 31, 2024 2.32 Bn
Dec 31, 2023 2.32 Bn
Sep 30, 2023 2.36 Bn
Jun 30, 2023 2.35 Bn
Mar 31, 2023 2.37 Bn
Dec 31, 2022 2.40 Bn
Sep 30, 2022 2.62 Bn
Jun 30, 2022 2.60 Bn
Dec 31, 2021 2.55 Bn